Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket

Gainers

• China Natural Resources, Inc. CHNR shares surged 63.5% to $3.22 in pre-market trading after the company agreed to sell all outstanding shares of Precise Space-Time Technology Limited to Feishang Group Limited, together with PSTT's outstanding payable owed to the Company, for consideration of around RMB95,761,119 in cash.
• FOXO Technologies Inc. FOXO rose 45.3% to $0.1941 in pre-market trading.
• Aurora Acquisition Corp. AURC gained 29.6% to $57.08 in pre-market trading after jumping 113% on Friday
• Nano Labs Ltd NA shares gained 25% to $1.80 in pre-market trading after the company reported receipt of interest-free loans from shareholders.
• Connexa Sports Technologies Inc. CNXA shares rose 18% to $0.1533 in pre-market trading.
• Inpixon INPX shares gained 16.6% to $0.2814 in pre-market trading after jumping 19% on Friday.
• Barnes & Noble Education, Inc. BNED shares climbed 16% to $1.45 in pre-market trading after the company entered into an agreement with key financial stakeholders and strategic partners to strengthen financial position and support growth initiatives.
• Visionary Education Technology Holdings Group Inc. VEDU shares rose 14.5% to $0.4479 in pre-market trading after gaining 5% on Friday.
• Apellis Pharmaceuticals, Inc. APLS gained 13.9% to $36.47 in pre-market trading after the company issued an update on review of rare safety events with Syfovre for geographic atrophy.
• Eos Energy Enterprises, Inc. EOSE rose 11.5% to $2.52 in pre-market trading. Eos Energy Enterprises said it expects to record revenue of $0.2 million for the quarter ended June 30, 2023.

Losers

• Navidea Biopharmaceuticals, Inc. NAVB fell 22.4% to $0.0737 in pre-market trading after the company announced NYSE American has commenced delisting proceedings and the company intends to appeal.
• Unique Fabricating, Inc. UFAB fell 17.6% to $0.2850 in pre-market trading after gaining 60% on Friday.
• Sonnet BioTherapeutics Holdings, Inc. SONN fell 16.3% to $0.2850 in pre-market trading. Sonnet BioTherapeutics, last month, announced a $2.25 million registered direct offering of 5 million at $0.45/share.
• Troika Media Group, Inc. TRKA shares fell 9.7% to $2.33 in pre-market trading after gaining over 7% on Friday.
• Citius Pharmaceuticals, Inc. CTXR fell 9% to $1.02 in pre-market trading after the company received FDA Complete Response Letter for Lymphir (Denileukin Diftitox) for relapsed/refractory cutaneous T-cell lymphoma.
• Satixfy Communications Ltd. SATX shares fell 9.6% to $0.2985 in pre-market trading. SatixFy Communications recently named Mr. Nir Barkan as Acting Chief Executive Officer.
• BioNexus Gene Lab Corp. BGLC fell 8.7% to $2.74 in pre-market after jumping over 40% on Friday.
• Akari Therapeutics, Plc AKTX fell 8.2% to $0.2001 in pre-market trading. Akari Therapeutics was recently granted Nomacopan Orphan Drug Designation from the European Commission for treatment in hematopoietic stem cell transplantation.
• Greenbrook TMS Inc. GBNH shares fell 6.8% to $0.4685 in pre-market trading.
• Femasys Inc. FEMY fell 6.8% to $0.6061 in pre-market trading after dipping over 22% on Friday.

Now Read This: Market Volatility Falls Following June PCE Data; S&P 500 Settles Higher